Rockwell Medical Inc
NASDAQ:RMTI

Watchlist Manager
Rockwell Medical Inc Logo
Rockwell Medical Inc
NASDAQ:RMTI
Watchlist
Price: 2.13 USD -4.48% Market Closed
Market Cap: 68.8m USD
Have any thoughts about
Rockwell Medical Inc?
Write Note

Rockwell Medical Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rockwell Medical Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Rockwell Medical Inc
NASDAQ:RMTI
Cash from Operating Activities
$3.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Cash from Operating Activities
$85m
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
ICU Medical Inc
NASDAQ:ICUI
Cash from Operating Activities
$255.1m
CAGR 3-Years
-1%
CAGR 5-Years
20%
CAGR 10-Years
14%
Align Technology Inc
NASDAQ:ALGN
Cash from Operating Activities
$522.6m
CAGR 3-Years
-26%
CAGR 5-Years
-7%
CAGR 10-Years
9%
Lantheus Holdings Inc
NASDAQ:LNTH
Cash from Operating Activities
$499.3m
CAGR 3-Years
131%
CAGR 5-Years
46%
CAGR 10-Years
46%
Merit Medical Systems Inc
NASDAQ:MMSI
Cash from Operating Activities
$214.3m
CAGR 3-Years
16%
CAGR 5-Years
24%
CAGR 10-Years
16%
No Stocks Found

Rockwell Medical Inc
Glance View

Market Cap
68.8m USD
Industry
Health Care

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 300 full-time employees. The firm is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. The company is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The firm has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.

RMTI Intrinsic Value
1.23 USD
Overvaluation 42%
Intrinsic Value
Price

See Also

What is Rockwell Medical Inc's Cash from Operating Activities?
Cash from Operating Activities
3.3m USD

Based on the financial report for Sep 30, 2024, Rockwell Medical Inc's Cash from Operating Activities amounts to 3.3m USD.

Back to Top